Susquehanna International Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.8M | Sell |
471,800
-101,500
| -18% | -$8.37M | ﹤0.01% | 1514 |
|
|
2025
Q4 | $48.9M | Buy |
573,300
+68,700
| +14% | +$5.64M | 0.01% | 1383 |
|
|
2025
Q3 | $39.2M | Buy |
504,600
+13,200
| +3% | +$1.03M | ﹤0.01% | 1534 |
|
|
2025
Q2 | $38.4M | Sell |
491,400
-34,900
| -7% | -$2.6M | 0.01% | 1374 |
|
|
2025
Q1 | $38.1M | Sell |
526,300
-467,000
| -47% | -$33.4M | 0.01% | 1198 |
|
|
2024
Q4 | $73.5M | Sell |
993,300
-625,200
| -39% | -$43.8M | 0.01% | 882 |
|
|
2024
Q3 | $107M | Buy |
1,618,500
+1,143,800
| +241% | +$83.1M | 0.02% | 614 |
|
|
2024
Q2 | $43.8M | Buy |
474,700
+37,600
| +9% | +$3.33M | 0.01% | 1075 |
|
|
2024
Q1 | $41.8M | Sell |
437,100
-201,000
| -31% | -$16.9M | 0.01% | 1159 |
|
|
2023
Q4 | $48.7M | Buy |
638,100
+119,900
| +23% | +$8.34M | 0.01% | 1057 |
|
|
2023
Q3 | $35.9M | Buy |
518,200
+111,900
| +28% | +$8.99M | 0.01% | 1244 |
|
|
2023
Q2 | $38.3M | Buy |
406,300
+73,100
| +22% | +$6.35M | 0.01% | 1176 |
|
|
2023
Q1 | $27.6M | Sell |
333,200
-121,200
| -27% | -$9.53M | 0.01% | 1381 |
|
|
2022
Q4 | $33.9M | Sell |
454,400
-13,500
| -3% | -$1.04M | 0.01% | 1115 |
|
|
2022
Q3 | $38.7M | Buy |
467,900
+49,000
| +12% | +$4.71M | 0.01% | 958 |
|
|
2022
Q2 | $39.8M | Buy |
418,900
+103,400
| +33% | +$10.7M | 0.01% | 969 |
|
|
2022
Q1 | $37.1M | Sell |
315,500
-187,600
| -37% | -$21M | 0.01% | 1189 |
|
|
2021
Q4 | $65.2M | Sell |
503,100
-67,700
| -12% | -$7.9M | 0.01% | 939 |
|
|
2021
Q3 | $64.6M | Sell |
570,800
-54,500
| -9% | -$6.22M | 0.01% | 1004 |
|
|
2021
Q2 | $64.8M | Buy |
625,300
+334,500
| +115% | +$31.5M | 0.01% | 1017 |
|
|
2021
Q1 | $24.3M | Sell |
290,800
-406,600
| -58% | -$34.4M | ﹤0.01% | 1666 |
|
|
2020
Q4 | $63.6M | Sell |
697,400
-54,100
| -7% | -$4.49M | 0.01% | 881 |
|
|
2020
Q3 | $60M | Buy |
751,500
+36,500
| +5% | +$2.85M | 0.01% | 780 |
|
|
2020
Q2 | $49.4M | Sell |
715,000
-124,100
| -15% | -$8.82M | 0.01% | 832 |
|
|
2020
Q1 | $52.8M | Buy |
839,100
+69,000
| +9% | +$4.98M | 0.02% | 630 |
|
|
2019
Q4 | $59.9M | Sell |
770,100
-296,400
| -28% | -$23.1M | 0.02% | 717 |
|
|
2019
Q3 | $78.2M | Buy |
1,066,500
+328,800
| +45% | +$23.1M | 0.03% | 539 |
|
|
2019
Q2 | $45.4M | Sell |
737,700
-463,500
| -39% | -$28M | 0.02% | 751 |
|
|
2019
Q1 | $76.6M | Buy |
1,201,200
+340,200
| +40% | +$19.4M | 0.03% | 451 |
|
|
2018
Q4 | $44M | Sell |
861,000
-633,300
| -42% | -$32M | 0.02% | 657 |
|
|
2018
Q3 | $86.7M | Buy |
1,494,300
+563,400
| +61% | +$27.6M | 0.03% | 487 |
|
|
2018
Q2 | $45.2M | Buy |
930,900
+346,200
| +59% | +$16.2M | 0.02% | 745 |
|
|
2018
Q1 | $27.2M | Sell |
584,700
-111,900
| -16% | -$4.86M | 0.01% | 1010 |
|
|
2017
Q4 | $26.2M | Sell |
696,600
-120,900
| -15% | -$4.44M | 0.01% | 1066 |
|
|
2017
Q3 | $29.8M | Buy |
817,500
+130,200
| +19% | +$4.97M | 0.01% | 950 |
|
|
2017
Q2 | $27.1M | Sell |
687,300
-264,000
| -28% | -$9.64M | 0.01% | 933 |
|
|
2017
Q1 | $29.8M | Buy |
951,300
+522,900
| +122% | +$16.4M | 0.02% | 817 |
|
|
2016
Q4 | $13.4M | Sell |
428,400
-1,200
| -0.3% | -$38.9K | 0.01% | 1312 |
|
|
2016
Q3 | $17.3M | Sell |
429,600
-48,300
| -10% | -$1.82M | 0.01% | 1127 |
|
|
2016
Q2 | $15.9M | Sell |
477,900
-320,100
| -40% | -$11M | 0.01% | 1115 |
|
|
2016
Q1 | $23.5M | Sell |
798,000
-325,500
| -29% | -$8.98M | 0.01% | 896 |
|
|
2015
Q4 | $29.6M | Sell |
1,123,500
-163,500
| -13% | -$4.25M | 0.01% | 875 |
|
|
2015
Q3 | $30.5M | Buy |
1,287,000
+495,600
| +63% | +$12M | 0.01% | 904 |
|
|
2015
Q2 | $18.8M | Buy |
791,400
+564,000
| +248% | +$12.7M | 0.01% | 1360 |
|
|
2015
Q1 | $5.4M | Sell |
227,400
-328,800
| -59% | -$7.38M | ﹤0.01% | 2635 |
|
|
2014
Q4 | $11.8M | Buy |
556,200
+21,000
| +4% | +$422K | ﹤0.01% | 1853 |
|
|
2014
Q3 | $9.11M | Sell |
535,200
-313,800
| -37% | -$4.95M | ﹤0.01% | 2209 |
|
|
2014
Q2 | $12.1M | Sell |
849,000
-1,086,000
| -56% | -$14.7M | 0.01% | 1906 |
|
|
2014
Q1 | $23.9M | Buy |
1,935,000
+1,148,400
| +146% | +$13.3M | 0.01% | 1117 |
|
|
2013
Q4 | $8.62M | Sell |
786,600
-725,400
| -48% | -$8.18M | ﹤0.01% | 2232 |
|
|
2013
Q3 | $17.5M | Sell |
1,512,000
-232,800
| -13% | -$2.72M | 0.01% | 1326 |
|
|
2013
Q2 | $19.5M | Buy |
+1,744,800
| New | +$20.7M | 0.01% | 1141 |
|
Other funds holding EW
VCM
VPM
Susquehanna International Group's EW Position: Q1 2026 in Review
Susquehanna International Group reduced its Edwards Lifesciences (EW) stake by 59% in Q1 2026, selling an estimated $14.1M and leaving 119,419 shares worth $9.56M. The position accounts for ﹤0.01% of the portfolio, ranked #3179.
Susquehanna International Group first reported a position in EW in Q2 2013 and has held it in 50 quarters since. The position peaked at $37.5M in Q4 2013. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Susquehanna International Group held 119,419 shares of Edwards Lifesciences worth $9.56M as of Q1 2026.
- Susquehanna International Group sold 170,552 Edwards Lifesciences shares in Q1 2026, an estimated $14.1M.
- Edwards Lifesciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3179 holding.
- Susquehanna International Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 50 quarters since.
- Susquehanna International Group's Edwards Lifesciences position peaked at $37.5M in Q4 2013.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.